Fidelity Investments
TNGX icon

Fidelity Investments’s Tango Therapeutics TNGX Stock Holding History

Fidelity Investments’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386M Buy
12,333,339
+2,427,420
+25% +$60M 0.02% 652
2026
Q1 		$207M Buy
9,905,919
+7,038,371
+245% +$98M 0.01% 832
2025
Q4 		$25.4M Buy
2,867,548
+2,861,122
+44,524% +$24.7M ﹤0.01% 1686
2025
Q3 		$54K Buy
6,426
+848
+15% +$5.74K ﹤0.01% 3936
2025
Q2 		$28.6K Sell
5,578
-5,164
-48% -$12.8K ﹤0.01% 4143
2025
Q1 		$14.7K Buy
10,742
+1,905
+22% +$4.68K ﹤0.01% 4348
2024
Q4 		$27.3K Sell
8,837
-9,370,960
-100% -$43.5M ﹤0.01% 4106
2024
Q3 		$72.2M Sell
9,379,797
-29,281
-0.3% -$279K ﹤0.01% 1222
2024
Q2 		$80.7M Sell
9,409,078
-82,577
-0.9% -$638K 0.01% 1136
2024
Q1 		$75.4M Sell
9,491,655
-295,695
-3% -$3.17M 0.01% 1167
2023
Q4 		$96.9M Sell
9,787,350
-1,858,391
-16% -$16.1M 0.01% 1028
2023
Q3 		$131M Buy
11,645,741
+1,276,945
+12% +$7.79M 0.01% 859
2023
Q2 		$34.4M Buy
10,368,796
+859,867
+9% +$3.09M ﹤0.01% 1416
2023
Q1 		$37.6M Buy
9,508,929
+425,250
+5% +$2.47M ﹤0.01% 1363
2022
Q4 		$65.9M Buy
9,083,679
+2,045,339
+29% +$14.4M 0.01% 1134
2022
Q3 		$25.5M Sell
7,038,340
-593,577
-8% -$2.53M ﹤0.01% 1532
2022
Q2 		$34.6M Buy
7,631,917
+755,942
+11% +$4.58M ﹤0.01% 1421
2022
Q1 		$52.1M Sell
6,875,975
-306,213
-4% -$2.65M ﹤0.01% 1375
2021
Q4 		$78.6M Buy
7,182,188
+930,275
+15% +$11.2M 0.01% 1214
2021
Q3 		$80.8M Buy
+6,251,913
New +$74.9M 0.01% 1196

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's TNGX Position: Q2 2026 in Review

Fidelity Investments increased its Tango Therapeutics (TNGX) stake by 25% in Q2 2026, buying an estimated $60M and bringing the position to 12,333,339 shares worth $386M. The position accounts for 0.02% of the portfolio, ranked #652.

Fidelity Investments first reported a position in TNGX in Q3 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Fidelity Investments held 12,333,339 shares of Tango Therapeutics worth $386M as of Q2 2026.
  • Fidelity Investments bought 2,427,420 Tango Therapeutics shares in Q2 2026, an estimated $60M.
  • Tango Therapeutics made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #652 holding.
  • Fidelity Investments first reported a position in Tango Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.